Advertisement

Topics

GRAIL, Inc. Company Profile

09:51 EDT 23rd June 2018 | BioPortfolio

GRAIL is a life sciences company whose mission is to detect cancer early when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical trials, and state of the art Computer Science and Data Science to enhance the scientific understanding of cancer biology and develop blood tests for early-stage cancer detection. The company’s funding was led by ARCH Venture Partners and includes Amazon, Bezos Expeditions, Bill Gates, Bristol-Myers Squibb, Celgene, Decheng Capital, GV, Illumina, Johnson & Johnson Innovation, Merck, McKesson Ventures, Sutter Hill Ventures, Tencent, Varian Medical Systems, and other financial partners. For more information, please visit www.grail.com.


News Articles [52 Associated News Articles listed on BioPortfolio]

Cancer blood test firm Grail mulls IPO

Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange. Citing several sources, Bloomberg reporte...

Grail, a US-Hong Kong Diagnostics Company, May Stage $500 Million Hong Kong IPO

Grail, a US spinout from Illumina that is developing blood-based cancer detection tests, is considering a $500 million Hong Kong IPO. Last year, Grail completed a $900 million Series B fundraising, th...

With $300M in New Round, Total Venture Funding at Grail Tops $1.5B

Grail, the Illumina (NASDAQ: ILMN) spinout that merged last year with China’s Cirina, has raised an additional $300 million to advance its ambitious quest to develop a blood test sensitive enough to...

Grail Raises $300 Million from China Investors for Early Cancer Diagnostics

Grail, a Hong Kong-US oncology diagnostics company, announced a $300 million C financing. Since early 2016, Grail has raised over $1.5 billion. The company is sequencing large populations of people --...

Ally Bridge Group mène la ronde de financement de série C de GRAIL représentant un montant ...

« Nous sommes très impressionnés par les réalisations scientifiques, cliniques et d'ingénierie logicielle que l'équipe de GRAIL a mené à bien en un peu plus de Read more...

Grail’s Asia incentives

An Asia strategy and higher valuations could tip the scales towards a Hong Kong IPO for Grail.

Funding round yields $300M for cancer detection firm Grail

An oversubscribed Series C financing round that included Chinese investors raised $300 million for Grail, a developer of bloo -More- 

Ally Bridge Group führender Investor einer Series-C-Finanzierung von GRAIL in Höhe von 300 ...

„Die wissenschaftlichen und klinischen Ergebnisse und die Fortschritte der Softwareentwicklung, die das Team von GRAIL während der letzten zwei Jahre erreicht hat, haben uns sehr Read more...

Drugs and Medications [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

The STRIVE Study: Breast Cancer Screening Cohort

GRAIL is using high-intensity sequencing of circulating cell-free nucleic acids (cfNAs) to develop blood tests to detect cancer early. The purpose of this study is to train and validate an...

Lung Cancer Screening Study Using Low Dose CT With Development and Evaluation of the GRAIL Test.

This study has two main aims. The first one is to examine how to deliver a lung cancer screening service in North Central and North East London and Essex. At the moment, the best way of f...

Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation

During the past 15 years, however, the superior immunosuppressive efficacy of CsA and the well-known toxicity of long-term steroid therapy have prompted trials of steroid withdrawal from r...

Ephedrine and Phenylephrine for Spinal Hypotension

Spinal anesthesia is widely used as the procedure of choice for cesarean delivery. In comparison to epidural anesthesia it is faster, easier to perform, patients are more comfortable, comp...

Companies [4 Associated Companies listed on BioPortfolio]

GRAIL

GRAIL is focused on detecting cancer at an early-stage, when it can be cured. The company secured over $100 million in Series A financing from Illumina, Inc. and ARCH Venture Part...

GRAIL, Inc.

GRAIL is a life sciences company whose mission is to detect cancer early when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical tri...

Heartlab

Like most successful companies, Heartlab began as a solution to a problem. In the late 1980’s, Robert Petrocelli, an engineer with expertise in real-time signal and image processing, started working...

Epeius Biotechnologies Corporation

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company focused on research, development, and commercialization of the first truly effective targeted delivery system (TDS) tha...

More Information about "GRAIL, Inc." on BioPortfolio

We have published hundreds of GRAIL, Inc. news stories on BioPortfolio along with dozens of GRAIL, Inc. Clinical Trials and PubMed Articles about GRAIL, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GRAIL, Inc. Companies in our database. You can also find out about relevant GRAIL, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...


Corporate Database Quicklinks



Searches Linking to this Company Record